WO1996025913A1 - Preparation - Google Patents
Preparation Download PDFInfo
- Publication number
- WO1996025913A1 WO1996025913A1 PCT/EP1996/000679 EP9600679W WO9625913A1 WO 1996025913 A1 WO1996025913 A1 WO 1996025913A1 EP 9600679 W EP9600679 W EP 9600679W WO 9625913 A1 WO9625913 A1 WO 9625913A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zinc
- hydroxycarbonate
- water
- monophasic
- personal care
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G9/00—Compounds of zinc
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Definitions
- This invention relates to preparation of zinc hydroxycarbonate and antimicrobial compositions containing that compound.
- This invention particularly relates to:
- compositions such as toothpastes, toothpowders, toilet soaps, skin creams, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate as an antimicrobial agent.
- Zinc hydroxycarbonate occurs in nature in the mineral hydrozincite. Generally sulphide ore bodies are overlain by deposits of smithsonite, calamine and hydrozincite. Franklinite, willemite and zincite occur in white crystalline lime stone in some places. Calcite, dolomite and sometimes quartz occurs as materials associated with zinc blend or sulphide.
- the monophasic zinc hydroxycarbonate prepared by the process of present invention has a structure similar to that of hydrozincite without any other impurity phases as may be present in the mineral.
- Basic zinc carbonate may be represented by
- Zn 4 (C0 3 ) . (0H) 6 . or Zn 5 (C0 S ) 2 . (OH) unfortunately and sometimes it is accompanied with ZnO.
- the monophasic zinc hydroxycarbonate of the present invention has the following formula
- divalent zinc ions can provide antimicrobial activity. If they are made available freely in soaps or cosmetic or dental formulations, they would contribute to the health care features of these products. But the zinc ions tend to affect colour, perfume, flavour, and/or taste of the cosmetic products, dental products or soaps, and they may reduce the shelf life of such products. Due to the structure of the hydrozincite (in which zinc is present in the form of stable covalent complexes) , free divalent zinc ions are not made available in the product. Thereby the shelf life of the health care products is improved.
- Zinc hydroxycarbonate is also an antimicrobial compound, and it is surprisingly found that when a personal care product containing it comes into contact with the skin or with the saliva in the mouth, or the microflora of the skin, scalp or hair, the zinc hydroxycarbonate in the presence of a surfactant such as soap and/or synthetic detergent shows a synergistic enhancement of the antimicrobial effect. Further its substantivity keeps it on the body to readily deliver free divalent zinc ions to act as antimicrobial agent at the site as and when desired.
- a surfactant such as soap and/or synthetic detergent
- the zinc hydroxycarbonate not being soluble in water, is substantive to the skin, mucous membranes, hair, mould and microbial cell walls particularly wherever there is any acid site, and upon neutralising the acid site delivers divalent zinc ions which act on microbes which generate acids such as butyric and lactic acids.
- the surfactant e.g. soap and/or synthetic detergents place the zinc hydroxycarbonate onto the desired spot.
- the combination not only gives synergistic effect in antimicrobial activity in use but also gives triggered release effect during the intervening period inbetween successive application of the products containing it.
- zinc hydroxycarbonate acts as an agent to generate active antibacterial/antimicrobial species - divalent zinc ions - by its synergistic combination with surfactants such as soaps/synthetic detergents.
- This reference describes a process for the preparation of catalysts for synthesis of methanol from carbon oxides wherein a mixture of hydroxycarbonates of copper/zinc/aluminium/rare earth metal and/or zirconium is prepared by a co-precipitation technique.
- soluble salts are dissolved together and reacted with ammonium, sodium, potassium carbonates, and/or hydroxides n the pH range 6.3-7.3.
- This reference describes the preparation of an antimicrobial drug comprising supplying continuously aluminium, an aqueous solution of antimicrobial metal salts (including copper, zinc, magnesium, nickel and cobalt) , sodium carbonate solution and sodium hydroxide solution into a reaction tank at room temperature keeping the pH of the reaction solution at 7 to 11 by adjusting the NaOH addition, filtering the reacted suspension, rinsing with water and drying.
- the molar ratio of aluminium and copper ion salt is 1:1 to 4:1.
- the present invention relates to
- antimicrobial personal care products such as toothpastes, toothpowders, soaps, skin cream, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate, and a surfactant such as soap or a synthetic detergent.
- the process of the present invention for the preparation of zinc hydroxycarbonate (suitable for use as antimicrobial agent in personal care compositions such as soaps, cosmetic - skin and hair- and dental formulations) comprises
- the soluble zinc salt may be chloride, sulphate or nitrate.
- the pH of the reaction is between 8-10; preferably about 9.
- the preferred temperature of the precipitation reaction is 50-98 °C; more preferred is 80-90 °C.
- the product of the reaction is air dried at temperature upto 150 °C. Vacuum drying may be used.
- the precipitated basic zinc carbonate obtained by the process of the invention was identified by XRD, IR, SEM Morphology and its Zn content was found to be between 54.75 to 59.55 %.
- the chemical formula was found to be
- X varies between 0 and 4 depending on the drying temperature and duration of drying.
- the antimicrobial personal care compositions of the invention comprise from 0.1 % to 20 % by weight of monophasic zinc hydroxycarbonate in combination with the usual ingredients of personal care compositions comprising a soap or detergent, with or without other antimicrobial agents.
- the material obtained is not suitable for cosmetic use. It is more gritty than required.
- sodium carbonate solution and the zinc salt solution are simultaneously pumped in the precipitation vessel, the physical properties of the material obtained are very close to the requirement of the formulations.
- Zinc hydroxycarbonate shows synergistic antimicrobial activity in toothpastes with any abrasive agents such as chalk, silica, dicalciumphosphate dihydrate (DCPD) , alumina trihydrate.
- any abrasive agents such as chalk, silica, dicalciumphosphate dihydrate (DCPD) , alumina trihydrate.
- the zinc hydroxycarbonate neutralises organic acids such as lactic acid as and when they are generated in the mouth, and the release of zinc ions is triggered off as a result of this neutralisation of zinc with e.g. lactic acid acting on oral microflora. This process is likely to help to reduce plaque pH and buffer the plaque.
- This is another facet of the invention.
- Synergistic action of zinc hydroxycarbonate with detergent and/or antidandruff actives like zinc pyrithione in shampoos/hair dressings is yet another aspect of this invention.
- Synergistic action of zinc hydroxycarbonate in skin cream and talcum powder is yet another example of this invention. It has the added advantage of reducing body malodour caused by some of the fatty acids, hydroxy acids and their breakdown products, present in body malodour.
- Zinc sulphate heptahydrate 300 g was dissolved in water (1000 ml) .
- Sodium carbonate 150 g was dissolved in water (1000 ml) .
- Soaps containing monophasic zinc hydroxycarbonate (ZHC) with and without trichlorocarbanilide (TCC) were evaluated for their antibacterial activity by the Bureau of Indian Standards' Test method given in IS 11479 - 1985.
- Soap base used in these compositions had 55 % TFM (12.5 % CNO) ; 24 % Structurant (talc) ; 1.5 % Tetrasodium pyrophosphate, 0.5 % sodium carbonate.
- Example 3 Evaluation of toothpastes containing zinc hydroxycarbonates
- the antimicrobial activity of the toothpaste was assessed by [the in-vitro method described below] estimating total viable count by spread plate technique as described in Medical Microbiology by R. Cruickshank, 11th Edn., 1965, pp 886-889.
- Toothpaste base* (0.1 % on the broth) 23.6
- Toothpaste base + 2 % ZHC
- SCMC Sodium carboxymethylcellulose
- Titanium dioxide 1.0 Sodium lauryl sulphate 2.5 2.5
- Sorbitol (70 %) and water were taken into a vacuum mixer fitted with a low speed scraper unit and a high speed homogeniser. Minor soluble compounds such as saccharin, monosodium phosphate etc. were added to obtain clear solution.
- the mixture was heated to 50 °C and mixture of SCMC and abrasive chalk/silica was added. The mixture was homogenised and thickening silica was subsequently added.
- detergents consisting of sodium lauryl sulphate and dodecyl benzene sulphonate predissolved in water were added.
- the batch was cooled to 40 °C. Zinc hydroxycarbonate was then added and mixing was continued. Flavour was added last to complete the batch.
- n-butyric acid 0.5 % solution
- zinc hydroxycarbonate 5g in 30 ml slurry
- the filtrate was analysed for soluble Zn++ ions and its pH was recorded.
Abstract
The invention relates to the use of monophasic zinc hydroxycarbonate as antimicrobial agent in personal care products, particularly in such products which also contain a surfactant such as a soap or a synthetic detergent. The invention also relates to a process for making the zinc hydroxycarbonate, whereby a solution of a soluble zinc salt and a solution of alkalimetal carbonate are fed simultaneously into a precipitation vessel to form a precipitate of monophasic zinc hydroxycarbonate.
Description
--
1
PREPARATION INTRODUCTION
This invention relates to preparation of zinc hydroxycarbonate and antimicrobial compositions containing that compound.
This invention particularly relates to:
a) preparation of monophasic zinc hydroxycarbonate suitable for use in personal care products such as toilet soaps and cosmetics like skin, scalp and/or hair products and dental products such as toothpastes, toothpowders, dental creams and
b) personal care compositions such as toothpastes, toothpowders, toilet soaps, skin creams, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate as an antimicrobial agent.
BACKGROUND
Zinc hydroxycarbonate occurs in nature in the mineral hydrozincite. Generally sulphide ore bodies are overlain by deposits of smithsonite, calamine and hydrozincite. Franklinite, willemite and zincite occur in white crystalline lime stone in some places. Calcite, dolomite and sometimes quartz occurs as materials associated with zinc blend or sulphide. The monophasic zinc hydroxycarbonate prepared by the process of present invention has a structure similar to that of hydrozincite without any other impurity phases as may be present in the mineral.
Basic zinc carbonate may be represented by
Zn4(C03) . (0H)6. or Zn5 (C0S) 2. (OH) „
and sometimes it is accompanied with ZnO.
The monophasic zinc hydroxycarbonate of the present invention has the following formula
Zn5(C03)2. (OH)j.x H20 (x = 0-4)
It is known that divalent zinc ions can provide antimicrobial activity. If they are made available freely in soaps or cosmetic or dental formulations, they would contribute to the health care features of these products. But the zinc ions tend to affect colour, perfume, flavour, and/or taste of the cosmetic products, dental products or soaps, and they may reduce the shelf life of such products. Due to the structure of the hydrozincite (in which zinc is present in the form of stable covalent complexes) , free divalent zinc ions are not made available in the product. Thereby the shelf life of the health care products is improved. Zinc hydroxycarbonate is also an antimicrobial compound, and it is surprisingly found that when a personal care product containing it comes into contact with the skin or with the saliva in the mouth, or the microflora of the skin, scalp or hair, the zinc hydroxycarbonate in the presence of a surfactant such as soap and/or synthetic detergent shows a synergistic enhancement of the antimicrobial effect. Further its substantivity keeps it on the body to readily deliver free divalent zinc ions to act as antimicrobial agent at the site as and when desired. It is hypothesised here that the zinc hydroxycarbonate, not being soluble in water, is substantive to the skin, mucous membranes, hair, mould and microbial cell walls particularly wherever there is any acid site, and upon neutralising the acid site delivers divalent zinc ions which act on microbes which generate acids such as butyric and lactic acids. The surfactant, e.g. soap and/or synthetic detergents place the zinc hydroxycarbonate onto the desired spot. Thus, it is thought that the combination
not only gives synergistic effect in antimicrobial activity in use but also gives triggered release effect during the intervening period inbetween successive application of the products containing it. Thus, zinc hydroxycarbonate acts as an agent to generate active antibacterial/antimicrobial species - divalent zinc ions - by its synergistic combination with surfactants such as soaps/synthetic detergents.
PRIOR ART
There are processes known for the preparation of basic zinc carbonate. Preparation of monophasic zinc hydroxycarbonate suitable for use in personal products has not been described. Use of mineral hydrozincite in dental preparations has been reported, but synergistic antimicrobial compositions containing zinc hydroxycarbonates have not been reported in the literature.
In a Russian process degradation of zinc ammonium carbonate complexes with hot moist air in the presence of lignin sulphonate gives zinc hydroxycarbonate. [Krechmer G.A. ; SU
664923 (30 May 1979) ] .
In another Russian process, basic zinc carbonate is prepared by an electro-chemical process from an electrolyte containing sodium nitrate and sodium bicarbonate. [Oratovskii V.I.; SU 447366 (22 August 1975)].
In another process, zinc hydroxide ( a waste product from the production of Na2S204 was used as raw material for the production of basic zinc carbonate (ZnC03.3Zn(OH)2) by carbonation. [Telepneva A.E. and Artemova V.A. , Tr. Ural. Nauch. -Issled. Khim. Inst. 1973, 24.. 26-8] .
Further prior art references are:
a. Inst. Francais D Petrole: EP 015586R (20 February 1985)
This reference describes a process for the preparation of catalysts for synthesis of methanol from carbon oxides wherein a mixture of hydroxycarbonates of copper/zinc/aluminium/rare earth metal and/or zirconium is prepared by a co-precipitation technique. In this process soluble salts are dissolved together and reacted with ammonium, sodium, potassium carbonates, and/or hydroxides n the pH range 6.3-7.3.
b. Fu-ii Chem. Ind. Co. : JP 5025052 (2 February 1993)
This reference describes the preparation of an antimicrobial drug comprising supplying continuously aluminium, an aqueous solution of antimicrobial metal salts (including copper, zinc, magnesium, nickel and cobalt) , sodium carbonate solution and sodium hydroxide solution into a reaction tank at room temperature keeping the pH of the reaction solution at 7 to 11 by adjusting the NaOH addition, filtering the reacted suspension, rinsing with water and drying. The molar ratio of aluminium and copper ion salt is 1:1 to 4:1.
c. Vian A. fit, al.. An Ouim. Ser. A.. 1984. 80(3) Suppl. 2 . 724-31 (Spanish) fCA: 103: 89773v1
According to this reference, in connection with recovery of zinc from ion-exchange wash liquors, used in the leaching of pyrite cinders, NaOH, Ca(0H)2, and A(OH)-Na2C03 mixture, (where A = Na, K, NH4) were used to precipitate zinc from zinc chloride solution. While NaOH produced a precipitate consisting of [ZnO and Zn5(OH)β.Cl2.H20] , A(0H) and Na2C03 mixtures gave a precipitate consisting mainly of [ZnO and
Zn5 (C03)2 (OH)β] with various proportions.
In French patent 2493704, the use of natural carbonates forming an isomorphic series with the calcite, more resistant to acids than Iceland Spar (this includes natural hydrozincite) has been reported for treatment or prevention of the troubles from demineralisation of hard tissues such as teeth.
DEFINITION OF THE INVENTION
Accordingly, the present invention relates to
a) a process for the preparation of monophasic zinc hydroxycarbonate suitable for use in personal care products and
b) antimicrobial personal care products such as toothpastes, toothpowders, soaps, skin cream, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate, and a surfactant such as soap or a synthetic detergent.
The process of the present invention for the preparation of zinc hydroxycarbonate, (suitable for use as antimicrobial agent in personal care compositions such as soaps, cosmetic - skin and hair- and dental formulations) comprises
(i) dissolving a soluble zinc sal ^in water and heating it, to keep the solution warm before use,
(ii) dissolving an alkali metal carbonate, such as sodium potassium or ammonium carbonate, in water,
(iii) taking water in a precipitation vessel and maintaining it at 35-95 °C,
(iv) pumping warm solutions of (i) and (ii) into the precipitation vessel simultaneously, and maintaining the temperature at 50-98 °C with continuous stirring and warming if necessary,
(v) filtering off the precipitate and washing it with water until it is free from anions, and
(vi) drying the washed material.
The soluble zinc salt may be chloride, sulphate or nitrate. The pH of the reaction is between 8-10; preferably about 9.
The preferred temperature of the precipitation reaction is 50-98 °C; more preferred is 80-90 °C.
The product of the reaction is air dried at temperature upto 150 °C. Vacuum drying may be used.
The precipitated basic zinc carbonate obtained by the process of the invention was identified by XRD, IR, SEM Morphology and its Zn content was found to be between 54.75 to 59.55 %. The chemical formula was found to be
Zn5(OH)β(C03)2.X.H20
X varies between 0 and 4 depending on the drying temperature and duration of drying.
The antimicrobial personal care compositions of the invention comprise from 0.1 % to 20 % by weight of monophasic zinc hydroxycarbonate in combination with the usual ingredients of personal care compositions comprising a soap or detergent, with or without other antimicrobial agents.
DETAILS OF THE INVENTION
If the sodium carbonate solution is taken in the precipitation vessel initially, and zinc salt solution is thereafter pumped into it or vice versa, the material obtained is not suitable for cosmetic use. It is more gritty than required. On the other hand when sodium carbonate solution and the zinc salt solution are simultaneously pumped in the precipitation vessel, the physical properties of the material obtained are very close to the requirement of the formulations.
When the zinc hydroxycarbonate is prepared as above by precipitation at different temperatures viz., 50, 70 and 85 °C it has been found that all these products exhibit a hydrozincite structure. However, when it is precipitated at room temperature, the product is not monophasic.
Synergistic action of zinc hydroxycarbonate with soaps containing TCC (trichlorocarbanilide) is another facet of this invention.
Synergistic action of zinc hydroxycarbonate with toothpastes containing soaps and/or detergents such as sodium ricinoleate, sodium lauryl sulphate, is yet another facet of this invention. Zinc hydroxycarbonate shows synergistic antimicrobial activity in toothpastes with any abrasive agents such as chalk, silica, dicalciumphosphate dihydrate (DCPD) , alumina trihydrate.
The zinc hydroxycarbonate neutralises organic acids such as lactic acid as and when they are generated in the mouth, and the release of zinc ions is triggered off as a result of this neutralisation of zinc with e.g. lactic acid acting on oral microflora. This process is likely to help to reduce plaque pH and buffer the plaque. This is another facet of the invention.
Synergistic action of zinc hydroxycarbonate with detergent and/or antidandruff actives like zinc pyrithione in shampoos/hair dressings is yet another aspect of this invention.
Synergistic action of zinc hydroxycarbonate in skin cream and talcum powder is yet another example of this invention. It has the added advantage of reducing body malodour caused by some of the fatty acids, hydroxy acids and their breakdown products, present in body malodour.
The neutralisation of organic acids such as butyric acid generated on skin which is responsible for malodour by the zinc hydroxycarbonate release zinc ions acting on the skin microflora. It also acts as a buffer to control the pH in the area of its action on skin. The synergistic compositions such as deodorants, antiperspirants are based on this principle and it is another facet of the invention.
EXAMPLES
The invention will now be illustrated by way of Examples. The Examples are for illustration only and they do not in any way restrict the scope of the invention.
Example 1: Preparation of monophasic zinc hydroxycarbonate
Materials used in this Example were of technical grade.
1. Zinc sulphate heptahydrate (300 g) was dissolved in water (1000 ml) . Sodium carbonate (150 g) was dissolved in water (1000 ml) .
2. In the precipitation vessel (5000 ml) 200 ml water was taken and maintained at 85 °C.
3. Warm solutions of zinc sulphate and sodium carbonate
were pumped into the precipitation vessel simultaneously maintaining the precipitation temperature at 85 °C, with continuous stirring.
4. When all the solutions were added and the precipitation completed, the precipitate was filtered through a Buchner funnel, and washed with hot (60 °C) water (2000 ml) .
5. The product was dried in an air oven at 110 °C for six hours. Yield: 125 g (100 %) .
Analysis of the product :
Zn content:
55 % by wt. (EDTA Titration using Eriochrome Black T)
Surface Area: 80 m2/g (BET method)
X-Ray (powder) diffraction pattern: it indicated a highly crystalline nature of the product and it was isostructural with the mineral hydrozincite.
FT-IR Spectra: it indicated a basic carbonate group. [- absorption doublets at 1507 and 1385 cm _1. This was confirmed by adsorption maxima at 1046 (bridging type OH: bending mode) ; at 835 (out-of-plane C03 deformation) ; at 708 (in-plane C03 deformation) and at 470 cm"1 (ZnO symmetric stretching)] .
Example 2: Evaluation of soaps containing zinc hydroxycarbonate
Soaps containing monophasic zinc hydroxycarbonate (ZHC) with and without trichlorocarbanilide (TCC) were evaluated for their antibacterial activity by the Bureau of Indian
Standards' Test method given in IS 11479 - 1985.
Results are given in Table 1.
Table 1
Composi ion Subs ant-ivity
1. Soap base* No
2. Soap base + 0.1 % TCC No 3. Soap base + 0.5 % ZHC No
4. Soap base + 0.1 % TCC + 0.5 % ZHC Yes
* Soap base used in these compositions had 55 % TFM (12.5 % CNO) ; 24 % Structurant (talc) ; 1.5 % Tetrasodium pyrophosphate, 0.5 % sodium carbonate.
These results clearly showed that very small amounts of TCC when mixed with small amounts of ZHC synergistically reduced the microbial activity and improved substantivity much more than either of them individually with soap base.
Example 3: Evaluation of toothpastes containing zinc hydroxycarbonates
The antimicrobial activity of the toothpaste was assessed by [the in-vitro method described below] estimating total viable count by spread plate technique as described in Medical Microbiology by R. Cruickshank, 11th Edn., 1965, pp 886-889.
The results of the assay are given in Table 2.
Table 2 Antimicrobial activity of toothpastes containing zinc hydroxycarbonate
CP pQSi ΪQΠ % Inhibition
1. Toothpaste base*: (0.1 % on the broth) 23.6
2. Toothpaste base + 2 % ZHC:
(0.1 % - 20 ppm ZHC - on the broth) 86.2
3. 20 ppm ZHC (as slurry) on the broth 41.3
* Composition of the toothpaste base is same as that given in Example 4A without any addition of ZHC.
The results clearly indicated that the Composition 2 had a synergistic inhibitory activity.
In-vitro method:
Appropriate dilutions of toothpaste are incubated with a Streptococcus spp. culture isolated from the oral microflora. An aliquot of this is taken and placed on an Agar plate for growth at room temperature overnight. The following day colony forming units (CFU) are counted. The activity is expressed as % inhibition. This is calculated based on the growth of bacteria (no of CFUs) without any treatment, which is taken as 100 % growth or 0 % inhibition.
Example 4: Toothpaste compositions according to the invention
The following toothpaste compositions were formulated as described below:
Composition 4A(%) 4B(%)
Precipitated calcium carbonate (Chalk) 40.0
Abrasive silica 10.0 Thickening silica 1.5 8.3
Sorbitol (70 %) 27.0 45.0
Sodium carboxymethylcellulose (SCMC) 0.7 0.9
Sodium saccharin 0.2 0.2
Titanium dioxide 1.0 Sodium lauryl sulphate 2.5 2.5
Sodium dodecylbenzenesulphonate (40 %) 1.0 0.5
Monosodium phosphate 0.4
Zinc hdyroxycarbonate 2.0 2.0
Flavour q.s. q.s.
Demineralised water to 100 100
Method of preparation
Sorbitol (70 %) and water were taken into a vacuum mixer fitted with a low speed scraper unit and a high speed homogeniser. Minor soluble compounds such as saccharin, monosodium phosphate etc. were added to obtain clear solution. The mixture was heated to 50 °C and mixture of SCMC and abrasive chalk/silica was added. The mixture was homogenised and thickening silica was subsequently added. When the mixture was of consistent quality, detergents consisting of sodium lauryl sulphate and dodecyl benzene sulphonate predissolved in water were added. The batch was cooled to 40 °C. Zinc hydroxycarbonate was then added and mixing was continued. Flavour was added last to complete the batch.
Example 5: Nent-ralisation of zinc hydroxycarbona e with n- butyric acid
Various quantities of n-butyric acid (0.5 % solution) were added to zinc hydroxycarbonate (5g in 30 ml slurry) and the
filtrate was analysed for soluble Zn++ ions and its pH was recorded.
Results are given in table 3.
Table 3
Mole ratio of Soluble Zn++ ions pH of the butyric acid: ZHC in the filtrate filtrate (% zinc on ZHC weight)
0 Nil 6.6
4 42.58 6.0
6 61.92 5.9 10 81.02 5.8
12 100.0 5.5
This Example supported our hypothesis of triggered release action of ZHC and buffering of the pH of the solution.
Claims
1. An antimicrobial personal care product comprising a surfactant and an antimicrobial agent, characterised in that the antimicrobial agent is or comprises monophasic zinc hydroxycarbonate.
2. A product according to claim 1, characterised in that the monophasic zinc hydroxycarbonate is present in an amount of 0.1 - 20 % by weight of the product.
3. A product according to claim 1 or 2, characterised in that the surfactant is a soap or a synthetic detergent.
4. A product according to claims 1-3, characterised in that the personal care product is a toilet soap.
5. A product according to claims 1-3, characterised in that the personal care product is a toothpaste.
6. A process for the preparation of monophasic zinc hydroxycarbonate, suitable for use in the products according to claims 1-5, said process comprising the steps of (i) dissolving a soluble zinc salt in water and heating he resulting solution, (ii) dissolving an alkalimetal carbonate in water, (iii) placing water in a precipitation vessel and maintaining the water at a temperature of
- w between 35-95 °C,
(iv) placing the solutions i) and ii) simultaneously into the precipitation vessel with warm water according to iii) , and maintaining the temperature at 50-98 °C with continuous stirring,
(v) filtering-off the precipitate formed during step iv) and washing the filtrate with water until it is free from anions, and (vi) drying the washed material.
7. Use of monophasic zinc hydroxycarbonate as antimicrobial agent in personal care product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU48778/96A AU4877896A (en) | 1995-02-20 | 1996-02-14 | Preparation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9503240.5A GB9503240D0 (en) | 1995-02-20 | 1995-02-20 | Preparation |
GB9503240.5 | 1995-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996025913A1 true WO1996025913A1 (en) | 1996-08-29 |
Family
ID=10769861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1996/000679 WO1996025913A1 (en) | 1995-02-20 | 1996-02-14 | Preparation |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU4877896A (en) |
GB (1) | GB9503240D0 (en) |
MA (1) | MA23812A1 (en) |
WO (1) | WO1996025913A1 (en) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037859A1 (en) * | 1997-02-28 | 1998-09-03 | Fertin A/S | An oral composition suitable for use in oral hygiene and dental care |
US5968539A (en) * | 1997-06-04 | 1999-10-19 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria |
US6183763B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved immediate germ reduction |
US6183757B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing |
EP1074247A2 (en) * | 1999-07-20 | 2001-02-07 | Zschimmer & Schwarz Italiana S.p.A. | Cleansing or cosmetic compositions comprising zinc alkylsulphates and/or alky(poly)ethoxysulphates as surfactants and preservatives |
US6190675B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria |
US6190674B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Liquid antimicrobial cleansing compositions |
US6197315B1 (en) | 1997-06-04 | 2001-03-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria |
US6210695B1 (en) | 1997-06-04 | 2001-04-03 | The Procter & Gamble Company | Leave-on antimicrobial compositions |
US6214363B1 (en) | 1997-11-12 | 2001-04-10 | The Procter & Gamble Company | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria |
US6284259B1 (en) | 1997-11-12 | 2001-09-04 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria |
US6287583B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Low-pH, acid-containing personal care compositions which exhibit reduced sting |
US6287577B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria |
WO2003088957A1 (en) * | 2002-04-22 | 2003-10-30 | The Procter & Gamble Company | Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
JP2004269372A (en) * | 2003-03-05 | 2004-09-30 | Toshiko Hori | Composition for coating and applying to human body |
WO2004082647A1 (en) * | 2003-03-18 | 2004-09-30 | The Procter & Gamble Company | Composition comprising zinc-containing layered material with a high relative zinc lability |
WO2004082648A1 (en) * | 2003-03-18 | 2004-09-30 | The Procter & Gamble Company | Composition comprising particulate zinc materials having a defined crystallite size |
US7026308B1 (en) | 1999-06-25 | 2006-04-11 | The Procter & Gamble Company | Topical anti-microbial compositions |
ITMI20101153A1 (en) * | 2010-06-25 | 2011-12-26 | Farmaceutici Dott Ciccarelli S P A | USE OF ANTIBACTERIAL COMPOUNDS FOR ORAL CABLE HYGIENE |
WO2013140136A1 (en) * | 2012-03-19 | 2013-09-26 | Isis Innovation Ltd | Adjuvants |
US8778311B2 (en) | 2006-03-22 | 2014-07-15 | The Procter & Gamble Company | Oral zinc compositions |
US8796252B2 (en) | 1999-06-25 | 2014-08-05 | Arch Chemicals, Inc. | Pyrithione biocides enhanced by zinc metal ions and organic amines |
WO2014134731A1 (en) * | 2013-03-07 | 2014-09-12 | Kane Biotech Inc. | Antimicrobial-antibiofilm compositions and methods of use thereof |
CN107847522A (en) * | 2015-06-12 | 2018-03-27 | 杰富意矿物股份有限公司 | Skin trauma or pachylosis therapeutic agent |
WO2018105739A1 (en) * | 2016-12-09 | 2018-06-14 | Jfeミネラル株式会社 | Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor |
WO2019011553A1 (en) * | 2017-07-11 | 2019-01-17 | Beiersdorf Ag | Use of electrolytes in cosmetic preparations for selectively reducing a microorganism population on human skin |
US10945935B2 (en) | 2016-06-27 | 2021-03-16 | The Procter And Gamble Company | Shampoo composition containing a gel network |
US11497691B2 (en) | 2018-12-14 | 2022-11-15 | The Procter & Gamble Company | Shampoo composition comprising sheet-like microcapsules |
US11628126B2 (en) | 2018-06-05 | 2023-04-18 | The Procter & Gamble Company | Clear cleansing composition |
US11633072B2 (en) | 2021-02-12 | 2023-04-25 | The Procter & Gamble Company | Multi-phase shampoo composition with an aesthetic design |
US11896689B2 (en) | 2019-06-28 | 2024-02-13 | The Procter & Gamble Company | Method of making a clear personal care comprising microcapsules |
US11932448B2 (en) | 2020-02-14 | 2024-03-19 | The Procter & Gamble Company | Bottle adapted for storing a liquid composition with an aesthetic design suspended therein |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2493704A1 (en) * | 1980-11-07 | 1982-05-14 | Lemouel Jean | Compsns. for dental caries and bone demineralisation - contg. an acid:resistant natural carbonate |
-
1995
- 1995-02-20 GB GBGB9503240.5A patent/GB9503240D0/en active Pending
-
1996
- 1996-02-14 WO PCT/EP1996/000679 patent/WO1996025913A1/en active Application Filing
- 1996-02-14 AU AU48778/96A patent/AU4877896A/en not_active Abandoned
- 1996-02-19 MA MA24169A patent/MA23812A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2493704A1 (en) * | 1980-11-07 | 1982-05-14 | Lemouel Jean | Compsns. for dental caries and bone demineralisation - contg. an acid:resistant natural carbonate |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037859A1 (en) * | 1997-02-28 | 1998-09-03 | Fertin A/S | An oral composition suitable for use in oral hygiene and dental care |
US5968539A (en) * | 1997-06-04 | 1999-10-19 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria |
US6183763B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved immediate germ reduction |
US6183757B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing |
US6190675B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria |
US6190674B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Liquid antimicrobial cleansing compositions |
US6197315B1 (en) | 1997-06-04 | 2001-03-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria |
US6210695B1 (en) | 1997-06-04 | 2001-04-03 | The Procter & Gamble Company | Leave-on antimicrobial compositions |
US6287577B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria |
US6214363B1 (en) | 1997-11-12 | 2001-04-10 | The Procter & Gamble Company | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria |
US6284259B1 (en) | 1997-11-12 | 2001-09-04 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria |
US6287583B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Low-pH, acid-containing personal care compositions which exhibit reduced sting |
US7026308B1 (en) | 1999-06-25 | 2006-04-11 | The Procter & Gamble Company | Topical anti-microbial compositions |
US8796252B2 (en) | 1999-06-25 | 2014-08-05 | Arch Chemicals, Inc. | Pyrithione biocides enhanced by zinc metal ions and organic amines |
EP1074247A3 (en) * | 1999-07-20 | 2003-01-22 | Zschimmer & Schwarz Italiana S.p.A. | Cleansing or cosmetic compositions comprising zinc alkylsulphates and/or alky(poly)ethoxysulphates as surfactants and preservatives |
EP1074247A2 (en) * | 1999-07-20 | 2001-02-07 | Zschimmer & Schwarz Italiana S.p.A. | Cleansing or cosmetic compositions comprising zinc alkylsulphates and/or alky(poly)ethoxysulphates as surfactants and preservatives |
WO2003088957A1 (en) * | 2002-04-22 | 2003-10-30 | The Procter & Gamble Company | Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
JP2004269372A (en) * | 2003-03-05 | 2004-09-30 | Toshiko Hori | Composition for coating and applying to human body |
WO2004082647A1 (en) * | 2003-03-18 | 2004-09-30 | The Procter & Gamble Company | Composition comprising zinc-containing layered material with a high relative zinc lability |
WO2004082648A1 (en) * | 2003-03-18 | 2004-09-30 | The Procter & Gamble Company | Composition comprising particulate zinc materials having a defined crystallite size |
US8778311B2 (en) | 2006-03-22 | 2014-07-15 | The Procter & Gamble Company | Oral zinc compositions |
ITMI20101153A1 (en) * | 2010-06-25 | 2011-12-26 | Farmaceutici Dott Ciccarelli S P A | USE OF ANTIBACTERIAL COMPOUNDS FOR ORAL CABLE HYGIENE |
EP2399576A1 (en) | 2010-06-25 | 2011-12-28 | Farmaceutici Dott. Ciccarelli S.p.A. | Use of antibacterial compounds for the oral cavity hygiene |
WO2013140136A1 (en) * | 2012-03-19 | 2013-09-26 | Isis Innovation Ltd | Adjuvants |
WO2014134731A1 (en) * | 2013-03-07 | 2014-09-12 | Kane Biotech Inc. | Antimicrobial-antibiofilm compositions and methods of use thereof |
CN107847522A (en) * | 2015-06-12 | 2018-03-27 | 杰富意矿物股份有限公司 | Skin trauma or pachylosis therapeutic agent |
EP3308794A4 (en) * | 2015-06-12 | 2018-06-20 | JFE Mineral Company, Ltd. | Therapeutic agent for skin wound or rough skin |
US10945935B2 (en) | 2016-06-27 | 2021-03-16 | The Procter And Gamble Company | Shampoo composition containing a gel network |
WO2018105739A1 (en) * | 2016-12-09 | 2018-06-14 | Jfeミネラル株式会社 | Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor |
JPWO2018105739A1 (en) * | 2016-12-09 | 2019-10-24 | Jfeミネラル株式会社 | INORGANIC COMPOSITION EXCELLENT IN ZINC ION SUSTAINED RELEASE AND METHOD FOR PRODUCING THE SAME |
US20200078396A1 (en) * | 2016-12-09 | 2020-03-12 | Jfe Mineral Company, Ltd. | Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor |
US10987380B2 (en) | 2016-12-09 | 2021-04-27 | Jfe Mineral Company, Ltd. | Hydrozincite containing zinc carbonate hydroxide hydrate and method of making |
WO2019011553A1 (en) * | 2017-07-11 | 2019-01-17 | Beiersdorf Ag | Use of electrolytes in cosmetic preparations for selectively reducing a microorganism population on human skin |
US11628126B2 (en) | 2018-06-05 | 2023-04-18 | The Procter & Gamble Company | Clear cleansing composition |
US11497691B2 (en) | 2018-12-14 | 2022-11-15 | The Procter & Gamble Company | Shampoo composition comprising sheet-like microcapsules |
US11896689B2 (en) | 2019-06-28 | 2024-02-13 | The Procter & Gamble Company | Method of making a clear personal care comprising microcapsules |
US11932448B2 (en) | 2020-02-14 | 2024-03-19 | The Procter & Gamble Company | Bottle adapted for storing a liquid composition with an aesthetic design suspended therein |
US11633072B2 (en) | 2021-02-12 | 2023-04-25 | The Procter & Gamble Company | Multi-phase shampoo composition with an aesthetic design |
Also Published As
Publication number | Publication date |
---|---|
AU4877896A (en) | 1996-09-11 |
GB9503240D0 (en) | 1995-04-12 |
MA23812A1 (en) | 1996-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996025913A1 (en) | Preparation | |
Enax et al. | Synthetic hydroxyapatite as a biomimetic oral care agent. | |
KR101091413B1 (en) | New crystalline pyrithione/zinc oxide composite and physiologic/antibiotic composition containing the same | |
EP2812010B1 (en) | Multicomponent oral care composition | |
CN100455569C (en) | Novel pyrithione complex compound, process for producing the same and use thereof | |
JP2003226630A (en) | Preparation with deodorizing activity comprising zinc salt of ricinoleic acid and at least one functional amino acid | |
KR20100043211A (en) | Diaphragm analysis method and use of products obtained using the method | |
CA1198738A (en) | Oral compositions comprising n.sup.g-acyl derivatives of arginine | |
CN105764479B (en) | Liquid oral detergent | |
CN108014287A (en) | A kind of effervesce bacteria inhibition tablet and preparation method thereof | |
KR101625626B1 (en) | Soap composition comprising baked shell powder | |
JPH07116008B2 (en) | Antibacterial agent | |
JP2006199659A (en) | Deodorizing and antiperspirant agent | |
JPS6240323B2 (en) | ||
JP2004250374A (en) | Composition for oral cavity | |
KR101122760B1 (en) | Toothpsate composites using mineral and manufacturing method thereof | |
EP4333617A1 (en) | Functionalized biomimetic hydroxyapatite | |
EP0267994B1 (en) | The use of a metal complex for the manufacture of a composition for treating dental structures | |
JPH05155733A (en) | Antiseptic agent for cosmetic and antibacterial cosmetic | |
JP2865380B2 (en) | Antibacterial cosmetic | |
EP3542776B1 (en) | Metal-carbon structure hybrid formulation for dental use in the treatment of dental hypersensitivity, demineralisation and cavities | |
JP2738942B2 (en) | Oral composition containing bivalent and trivalent complex iron salt | |
CA1290252C (en) | Method and compositions for treating dental structures | |
KR20110020971A (en) | The method of preparing soap using mineral water and it's soap | |
CN116196222A (en) | Caries preventing additive, caries preventing material, dental diaphragm and invisible appliance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AZ BY KG KZ RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |